AMPH Q1 2018 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$58M+3.0% YoY

Gross Profit

$17M29.2% margin

Operating Income

-$10M-17.0% margin

Net Income

-$7M-12.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

-$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$450M

Total Liabilities

$123M

Stockholders' Equity

$327M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$57M	+3.0%
Gross Profit	$17M	$23M	-25.3%
Operating Income	-$10M	$1M	-806.4%
Net Income	-$7M	$893,000	-911.4%

Revenue Segments

Active Pharmaceutical Ingredient Segment

$5M100%

Geographic Segments

U

$53M100%